Chimeric cancer models

Details for Australian Patent Application No. 2004268639 (hide)

Owner AVEO Pharmaceuticals, Inc.

Inventors Rideout, William Iii; Zhou, Yinghui; Clark, Steven C.; Jacks, Tyler; Robinson, Murray O.; Heyer, Joerg; Depinho, Ronald A.

Agent Cullen & Co

Pub. Number AU-B-2004268639

PCT Pub. Number WO2005/020683

Priority 60/518,249 07.11.03 US; 60/499,277 28.08.03 US

Filing date 27 August 2004

Wipo publication date 10 March 2005

Acceptance publication date 23 October 2008

International Classifications

A01K 67/027 (2006.01) Rearing or breeding animals, not otherwise provided for - New breeds of vertebrates

C07K 14/82 (2006.01) Peptides having more than 20 amino acids - Translation products from oncogenes

Event Publications

13 April 2006 PCT application entered the National Phase

  PCT publication WO2005/020683 Priority application(s): WO2005/020683

25 May 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 24 Mar 2006

23 October 2008 Application Accepted

  Published as AU-B-2004268639

8 January 2009 Application for Amendment

  The nature of the amendment is: Add the co-inventors name to read O'Hagan, Ronan C.. Address for service in Australia - Cullen & Co Level 26 239 George Street Brisbane QLD 4000

9 April 2009 Amendment Made

  The nature of the amendment is: Add co-inventor name to read O'Hagan, Ronan C.

23 April 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004268641-Compositions useful for treating gastrointestinal motility disorders

2004268633-Using selective antagonists of persistent sodium current to treat neurological disorders and pain